Skip to main content

CervoMed Inc.

CRVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001053691

No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding CervoMed Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of CRVO: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders12120
Shares363.7K326.4K−37.2K (−10.2%)
Value$1.68M$2.48M+$799.7K (+47.6%)

New holders (2)

Institutions that held CervoMed Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to CRVO in Q4 2023
InstitutionSharesValue% of portfolio
CWM, LLC38,253$292.0K0.00%
Harbour Investments, Inc.66$5040.00%

Sold out (2)

Institutions that held CervoMed Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of CRVO in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Rock Springs Capital Management LP80,033$369.8K
Citigroup Inc1$5